world
Vacuna de Merck/Moderna reduce más del 40% riesgo de muerte o recurrencia de melanoma
El Economista
October 22, 2026
via El EconomistaYou're reading one story from Newsaly
Newsaly brings together 60,000+ newspaper articles, 30,000+ podcasts and 10,000+ magazine articles from around the world.
A World Of News, One Window.
Explore Today's NewsEs el primer estudio que demuestra que la combinación de una vacuna basada en mutaciones específicas del tumor de cada paciente.
Read the full story
Explore More On Newsaly
Voices (0)
Share a 15-second voice reaction. Voices automatically disappear after 10 days.
Sign in to record a voice on this article.
Be the first to share a voice on this article.